Skip to content
10-Q

Quarterly Report

GUIDED THERAPEUTICS INC GTHP

0001477932-22-008459

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 14, 2022 48.58M sh
Long Term Debt Q3 2022 · Sep 30, 2022 $0
Long Term Debt Q3 2022 · Dec 31, 2021 $22K
Cash And Equivalents Q3 2022 · Sep 30, 2022 $2.7M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $643K
Stockholders Equity Q3 2022 · Sep 30, 2022 −$2.65M
Stockholders Equity Q3 2022 · Jun 30, 2022 −$5.77M
Stockholders Equity Q3 2022 · Dec 31, 2021 −$5.45M
Stockholders Equity restated Q3 2022 · Sep 30, 2021 −$7.75M
Stockholders Equity restated Q3 2022 · Jun 30, 2021 −$7.99M
Stockholders Equity Q3 2022 · Dec 31, 2020 −$10.86M
Current Liabilities Q3 2022 · Sep 30, 2022 $5.15M
Current Liabilities Q3 2022 · Dec 31, 2021 $5.69M
Total Liabilities Q3 2022 · Sep 30, 2022 $6.52M
Total Liabilities Q3 2022 · Dec 31, 2021 $7.49M
Current Assets Q3 2022 · Sep 30, 2022 $3.49M
Current Assets Q3 2022 · Dec 31, 2021 $1.64M
Total Assets Q3 2022 · Sep 30, 2022 $3.87M
Total Assets Q3 2022 · Dec 31, 2021 $2.04M
Capex Q3 2022 · Sep 30, 2021 $10K
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$1.75M
Eps Diluted Q3 2022 · Sep 30, 2021 $0.00
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.14
Eps Basic Q3 2022 · Sep 30, 2021 $0.00
Eps Basic Q3 2022 · Sep 30, 2021 −$0.14
Sga Expense Q3 2022 · Sep 30, 2021 $407K
Sga Expense Q3 2022 · Sep 30, 2021 $1.75M
Rd Expense Q3 2022 · Sep 30, 2021 $16K
Rd Expense Q3 2022 · Sep 30, 2021 $52K
Net Income Q3 2022 · Sep 30, 2021 $68K
Net Income Q3 2022 · Sep 30, 2021 −$1.63M
Operating Income Q3 2022 · Sep 30, 2021 −$487K
Operating Income Q3 2022 · Sep 30, 2021 −$1.93M
Gross Profit Q3 2022 · Sep 30, 2021 −$23K
Gross Profit Q3 2022 · Sep 30, 2021 −$21K
Revenue Q3 2022 · Sep 30, 2021 $19K
Revenue Q3 2022 · Sep 30, 2021 $21K